Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Dec 2021 for Anaptysbio, INC, €37k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Hamza Suria: trading record in brief
Hamza Suria, listed as chief executive, appears in our data through filings on Anaptysbio, Inc shares, published by SEC (Form 4). Over a trading history stretching from 12 May 2021 to 20 December 2021, the count stands at 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 22 December 2021, the filings show an option exercise worth €37k in Anaptysbio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hamza Suria
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
36,645 shares@ US$1.1227.9% of flowCommon StockSEC:0001209191-21-070986:0
964 shares@ US$22.0314.2% of flowCommon StockSEC:0001209191-21-065173:0
6,059 shares@ US$1.124.5% of flowCommon StockSEC:0001209191-21-063263:0
36,646 shares@ US$1.1227.2% of flowCommon StockSEC:0001209191-21-062481:0
15,993 shares@ US$1.1211.8% of flowCommon StockSEC:0001209191-21-061975:0
10,000 shares@ US$1.127.3% of flowCommon StockSEC:0001209191-21-057077:0
10,000 shares@ US$1.127.1% of flowCommon StockSEC:0001209191-21-032377:0
7 of 7 declarations
